lkinibim.blogspot.com
Hematide is in a Phase III Renton led Onyx for nearly 15 stepping down in February 2008as president, CEO, chairmamn and a member of Onyx’s board. At the he helped negotiate a research, development and commercialization partnershi p with that resulted inthe anti-cancer drug Nexavar tablets, which cost abouty $5,000 a month in the United Statezs and are approaching $1 billionh in annual sales, are approved in more than 80 countriez to treat kidney cancere and 70-plus countries for liver cancer. Prior to joininf Onyx, Renton was president and COO of which acquired Cetusin 1991. Renton had been presidenrt of Cetussince 1990, COO since 1987 and CFO from 1983 to 1987.
Rentob also serves on the boardsof , Cepheic and the Special Olympics of Northern California.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment